Publications by authors named "J P Feighner"

Claim this Profile
C
Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
John P Feighner, Lev Sverdlov, Joseph Hlavka, Gabriela Nicolau, Kenneth Cartwright

Int Clin Psychopharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder.
Stuart A Montgomery, John P Feighner, Lev Sverdlov, Ram K Shrivastava, Lynn A Cunningham

Int J Neuropsychopharmacol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of systemic exposure to nemifitide following two methods of subcutaneous administration to healthy volunteers.
G Nicolau, J P Feighner, R Stout, J Hlavka, M Gutierrez

Biopharm Drug Dispos· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression.
David H Overstreet, Joseph Hlavka, John P Feighner, Gabriela Nicolau, Jeffrey S Freed

Psychopharmacology (Berl)· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment.
John P Feighner, Lev Sverdlov, Gabriela Nicolau, Henry B Abajian, Joseph Hlavka

Int J Neuropsychopharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis